The Visian ICL is a phakic intraocular lens (IOL) for correcting myopia and Hyperopia. The ICL surgery is an additive surgery; the Visian ICL does not replace the eye's natural lens. Instead, the ICL is placed between the iris and the natural lens through a brief surgical procedure.
The Visian ICL gives another option for treating refraction errors than Lasik. Now, patients who are seeking the latest approved procedures for vision correction and exceptional Quality of Vision or who want to avoid permanent alteration of corneal tissues and eye structure after Laser have another choice for correction of nearsightedness and farsightedness.
The Visian ICL is made from Collamer, a unique collagen co-polymer designed specifically for the Visian ICL lens. This lens material has greater biocompatibility than acrylic and silicone lenses used in other phakic IOLs. The Visian ICL is also foldable, requiring a smaller incision (3.0 mm) during the surgical procedure than other available Phakic lenses.
The safety and effectiveness of the Visian ICL implantation procedure has been proven with over 300,000 implants worldwide along with more than 14 years of CE approval and 7 years of U.S. FDA approval. The Visian ICL is meant to stay in the eye indefinitely. However, if overcorrection or under correction occurs, a complication develops, or a patient's vision changes, the Visian ICL can be removed or exchanged by a trained ophthalmic surgeon.
Patient satisfaction with the Visian ICL is very high; over 99 percent of patients in the clinical trial were extremely satisfied with their vision after the procedure!
The first phakic intraocular lens for correcting myopic astigmatism, the Visian Toric ICL is the toric version of the Visian ICL. Currently under review by the U.S. FDA. The CE approved Visian Toric ICL is currently available and has been used internationally for more than 10 years by most ICL surgeons worldwide.